The effect of UCN-01 (7-hydroxystaurosporine), a potent inhibitor of protein kinase C, on fractionated radiotherapy or daily chemotherapy of a murine fibrosarcoma

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 5, 1997, Pages 1153-1161

  Tsuchida, Emiko ^a,b,d   Urano, Muneyasu ^a,c  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b NIIGATA UNIVERSITY   (Japan)

^c Yamano ue Hospital   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

Author keywords

5 Fluorouracil; Cis Diamminedichloroplatinum; Fractionated radiotherapy; Growth regulation; Protein kinase C inhibitor; Repopulation; UCN 01 (7 hydroxystaurosporine)

Indexed keywords

7 HYDROXYSTAUROSPORINE; CISPLATIN; FLUOROURACIL; PROTEIN KINASE C INHIBITOR;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL SURVIVAL; CHEMOSENSITIVITY; DRUG EFFECT; FIBROSARCOMA; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR GROWTH;

EID: 0030679652     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00549-X     Document Type: Article

References (43)

1. Aihara, H.; Asaoka, Y.; Yoshida, K.; Nishizuka, Y. Sustained activation of protein kinase C is essential to HL-60 cell differentiation to macrophage. Proc. Natl. Acad. Sci. USA 88: 11062-11066; 1991.
2. Akinaga, S.; Gomi, K.; Morimoto, M.; Tamaoki, T.; Okabe, M. Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models. Cancer Res. 51:4888-4892; 1991.
3. Akinaga, S.; Nomura, K.; Gomi, K.; Okabe, M. Synergistic anti-tumor effect of UCN-01, a protein kinase (C) inhibitor, combined with various anti-cancer agents. Proc. Am. Assoc. Cancer Res. 33:514; 1992.
4. Akinaga, S.; Nomura, K.; Gomi, K.; Okabe, M. Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C. Cancer Chemother. Pharmacol. 32:183-189; 1993.
5. Akinaga, S.; Nomura, K.; Gomi, K.; Okabe, M. Protein kinase C, Cell cycle, Staurosporine. Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells. Cancer Chemother. Pharmacol. 33:273-280; 1994.
6. Araki, S.; Simada, Y.; Kaji, K.; Hayashi, H. Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cells. Biochem. Biophys. Res. Commun. 172:1081-1085; 1990.
7. Ardalan, B.; Glazer, R. An update on the biochemistry of 5-fluorouracil. Cancer Treat. Rev. 8:157-167; 1981.
8. Basu, A.; Teicher, B. A.; Lazo, J. S. Involvement of protein kinase C in phorbol ester-induced sensitization of HeLa cells to cis-diamminedichloroplatinum(II). J. Biol. Chem. 265:8451-8457; 1990.
9. 2-checkpoint inhibitor. Clin. Cancer Res. 2:791-797; 1996.
10. Chapman, J. D.; Doern, S. D.; Reuvers, A. P.; Gillespie, C. J.; Chatterjee, A.; Blakely, E. A.; Smith, K. C.; Tobias, C. A. Radioprotection by DMSO of mammalian cells exposed to X-rays and heavy charged-particle beams. Radiat. Environ. Biophys. 16:29-41; 1979.
11. Davis, L. S.; Lipsky, P. E. T cell activation induced by anti-CD3 antibodies requires prolonged stimulation of protein kinase C. Cell. Immunol. 118:208-221; 1989.
12. Farago, A.; Nishizuka, Y. Protein kinase C in transmembrane signalling. FEBS Lett. 268:350-354; 1990.
13. Forbes, I. J.; Zalewski, P. D.; Giannakis, C.; Cowled, P. A. Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester. Exp. Cell Res. 198:367-372; 1992.
14. Hallahan, D. E.; Virudachalam, S.; Schwartz, J. L.; Panje, N.; Mustafi, R.; Weichselbaum, R. R. Inhibition of protein kinases sensitizes human tumor cells to ionizing radiation. Radiat. Res. 129:345-350; 1992.
15. Hofmann, J.; Doppler, W.; Jakob, A.; Maly, K.; Posch, L.; Überall, F.; Grunicke, H. H. Enhancement of the antiproliferative effect of cis-diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C. Int. J. Cancer 42:382-388; 1988.
16. Housey, G. M.; Johnson, M. D.; Hsiao, W. L. W.; O'Brian, C. A.; Murphy, J. P.; Kirschmeier, P.; Weinstein, I. B. Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 52:343-354; 1988.
17. Isonishi, S.; Andrews, P. A.; Howell, S. B. Increased sensitivity to cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol 13-acetate. J. Biol. Chem. 265:3623-3627; 1990.
18. Jarvis, W. D.; Turner, A. J.; Povirk, L. F.; Traylor, R. S.; Grant, S. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 54: 1707-1714; 1994.
19. Kikkawa, U.; Kishimoto, A.; Nishizuka, Y. The protein kinase C family: Heterogeneity and its implications. Annu. Rev. Biochem. 58:31-44; 1989.
20. Kim, C. Y.; Giaccia, A. J.; Strulovici, B.; Brown, J. M. Differential expression of protein kinase C ε protein in lung cancer cell lines by ionising radiation. Br. J. Cancer 66:844-849; 1992.
21. Lush, R. M.; Senderowicz, A.; Figg, W. D.; Headlee, D.; Inoue, K.; Sausville, E. A. Surprising pharmacokinetics of UCN-01 in patients with refractory neoplasms may be due to high degree of protein binding. Proc. Am. Assoc. Cancer Res. 38:600; 1997.
22. McConkey, D. J.; Hartzell, P.; Jondal, M.; Orrenius, S. Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J. Biol. Chem. 264:13399-13402; 1989.
23. Mizuno, K.; Saido, T. C.; Ohno, S.; Tamaoki, T.; Suzuki, K. Staurosporine-related compounds, K252a and UCN-01, inhibit both cPKC and nPKC. FEBS Lett. 330:114-116; 1993.
24. Nishizuka, Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334:661-665; 1988.
25. Nishizuka, Y. Intracellular sinaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614; 1992.
26. O'Brian, C. A.; Ward, N. E. Biology of the protein kinase C family. Cancer Metast. Rev. 8:199-214; 1989.
27. Pinto, A. L.; Lippard, S. J. Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA. Biochem. Biophys. Acta 780:167-180; 1985.
28. Rüegg, U. T.; Burgess, G. M. Staurosporine, K-252 and UCN-01: Potent but nonspecific inhibitors of protein kinases. TiPS 10:218-220; 1989.
29. Seynaeve, C. M.; Stetler-Stevenson, M.; Sebers, S.; Kaur, G.; Sausville, E. A.; Worland, P. J. Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells. Cancer Res. 53:2081-2086; 1993.
30. Seynaeve, C. M.; Kazanietz, M. G.; Blumberg, P. M.; Sausville, E. A.; Worland, P. J. Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue. Mol. Pharmacol. 45:1207-1214; 1994.
31. 2 {d(pGpG)}]. Science 230: 412-417; 1985.
32. Sinclair, W. K. Cyclic X-ray responses in mammalian cells in vitro. Radiat. Res. 33:620-643; 1968.
33. Sorenson, C. M.; Barry, M. A.; Eastman, A. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J. Natl. Cancer Inst. 82:749-755; 1990.
34. Takahashi, I.; Kobayashi, E.; Asano, K.; Yoshida, M.; Nakano, H. UCN-01, a selective inhibitor of protein kinase C from Streptomyces. J. Antibiot. 40:1782-1784; 1987.
35. Takahashi, I.; Saitoh, Y.; Yoshida, M.; Sano, H.; Nakano, H.; Morimoto, M.; Tamaoki, T. UCN-01 and UCN-02, new selective inhibitors of protein kinase C II. Purification, physicochemical properties, structural determination and biological activities. J. Antibiot. 42:571-576; 1989.
36. ++ dependent protein kinase. Biochem. Biophys. Res. Commun. 135:397-402; 1986.
37. Tsuchida, E.; Tsuchida, M.; Urano, M. Synergistic cytotoxicity between a protein kinase C inhibitor, UCN-01, and monoclonal antibody to the epidermal growth factor receptor on MDA-468 cells. Cancer Biother. Radiopharmacol. 12:117-121; 1997.
38. Urano, M.; Nesumi, N.; Ando, K.; Koike, S.; Ohnuma, N. Repair of potentially lethal radiation damage in acute and chronically hypoxic tumor cells in vivo. Radiology 118:447-451; 1976.
39. Urano, M. Thermochemotherapy: From in vitro and in vivo experiments to potential clinical application. In: Urano, M.; Douple, E., eds. Hyperthermia and oncology, Vol. 4. Utrecht, The Netherlands: VSP; 1994:169-204.
40. Urano, M.; Reynolds, R.; Begley, J. Protein kinase C inhibitor as a potent inhibitor of accelerated repopulation during radiotherapy: I. Growth Inhibitory, cytotoxic, and indirect radiosensitizing effects of a staurosporine derivative (UCN-01) in vitro. Radiat. Oncol. Invest. 3:64-71; 1995.
41. Urano, M.; Nishimura, Y.; Yaes, R. The relative significance of repopulation and hypoxic clonogens in the fractionated radiotherapy of a mouse tumor. Radiat. Res. 142:204-211; 1995.
42. Wang, Q.; Worland, P. J.; Clark, J. L.; Carlson, B. A.; Sausville E. A. Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2. Cell Growth Differ. 6:927-936; 1995.
43. Withers, H. R.; Taylor, J. M. G.; Maciejewski, B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:131-146; 1988.